Clinical Trial Update: Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Rituxan (rituximab) for its effect on immunological recall responses to specific antigens in patients with Non-Hodgkin lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Biogen | Conditions: Non-Hodgkin's Lymphoma | Phase 4 | Status: COMPLETED